2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2024 MIPS Measure #178: Rheumatoid Arthritis (RA): Functional Status Assessment”
MIPS/CQM Archive
2024 MIPS Measure #180: Rheumatoid Arthritis (RA): Glucocorticoid Management
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2024 MIPS Measure #180: Rheumatoid Arthritis (RA): Glucocorticoid Management”
2024 MIPS Measure #181: Elder Maltreatment Screen and Follow-Up Plan
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description Percentage of patients aged 60 years and older withContinue reading “2024 MIPS Measure #181: Elder Maltreatment Screen and Follow-Up Plan”
2024 MIPS Measure #1: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Intermediate Outcome – High Priority Description Percentage of patients 18-75 years of age withContinue reading “2024 MIPS Measure #1: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)”
2024 MIPS Measure #5: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2024 MIPS Measure #5: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)”
2024 MIPS Measure #6: Coronary Artery Disease (CAD): Antiplatelet Therapy
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2024 MIPS Measure #6: Coronary Artery Disease (CAD): Antiplatelet Therapy”
2024 MIPS Measure #7: Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2024 MIPS Measure #7: Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)”
2024 MIPS Measure #8: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2024 MIPS Measure #8: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)”
2024 MIPS Measure #19: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description Percentage of patients aged 18 years and older withContinue reading “2024 MIPS Measure #19: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care”
2024 MIPS Measure #24: Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description Percentage of patients aged 50 years and older treatedContinue reading “2024 MIPS Measure #24: Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older”